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Interferon-induced 2-5A synthetases are probably involved in some antiviral actions of interferon. In hu- 
man cells two different mRNAs (1.6, 1.8 kb long) coding for this protein are transcribed from the same 
gene and are produced by differential splicing. The relationship between the two mRNAs of different size 
and the active enzyme is not clear, nor is the cellular localization of the latter known. We have cloned a 
cDNA corresponding to the 1.6 kb RNA. This cDNA was sequenced and its complete coding region was 
subcloned into pSP64. The resulting plasmid was used to direct the synthesis of micrograms of capped RNA 
transcript after linearization in the 3’-non-coding region. A 39 kDa protein was synthesized when this RNA 
was translated in rabbit reticulocyte lysate. When this capped RNA was introduced by microinjection into 
Xenopus oocytes, production of 2-SA synthetase was clearly observed in the cytoplasm and lO-30% of the 
enzyme accumulated with time in the nucleoplasm. Analysis of cytoplasmic homogenates of these oocytes 
on a glycerol gradient revealed that the enzyme is fully active in the monomeric form. 
Interferon induction cDNA Cfoning Transcription Translation 
1. INTRODUCTION 
Interferons (IFN) are a class of proteins and 
glycoproteins secreted by various cells in response 
to viral infection or to other inducers such as 
double-stranded RNA (dsRNA) [l-4]. A wide 
range of biological effects, including inhibition of 
virus replication, changes in cell membr~e, inhibi- 
tion of cell growth and modification of immune 
response, occur when interferons interact with 
discrete plasma membrane receptors [5]. Some of 
these effects at least are thought to be mediated by 
proteins whose synthesis is induced in cells after in- 
terferon treatment h&7]. Among these proteins, 
the 2-5A synthetase has been shown to be involved 
in some antiviral actions of interferon. In the 
presence of dsRNA, this enzyme catalyzes the syn- 
thesis of 2’ -5 ’ linked oligomers of adenosine, 
ppp(A2’p),A. Viral growth is inhibited through 
mRNA degradation mediated by a latent en- 
doribonuclease which is activated by these 2-5A 
oligomers. This effect is transient. The 2-5A 
oligomers are probably rapidly degraded by a 
2’ -phosphodiesterase [4]. In addition to this an- 
tiviral role, the 2-SA system seems to be involved 
in the regulation of cell growth and differentiation 
[5]. 2-5A synthetase activities associated with pro- 
teins of different sizes were detected in the 
cytoplasm and nucleoplasm [8,9]. Two functional 
mRNAs (1.6 and 1.8 kb in human cells [ IO,11 1 and 
1.8 and 3.6 kb in mouse cells [9]) were shown to 
encode synthetase activity. The relation between 
the different mRNAs, which seem to derive from 
the same gene by differential splicing flO,l 11, and 
the different proteins, as well as the cellular 
localization of the latter, is still not clear. In 
human cells a cytoplasmic IFN-inducible 2-5A 
synthetase activity mediated by a 80-105 kDa 
polypeptide as detected in SDS-polyacrylamide 
gels has been described [12,131. This observation is 
difficult to reconcile with the molecular mass and 
coding capacity described for the two 1.6 and 
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1.8 kb translatable forms of human 2-SA syn- 
thetase mRNAs described up until now [ 10, 1 1,141. 
So far no mRNA has been found which codes for 
the 105 kDa 2-5A synthetase described in human 
cells. Studies on the regulation, gene organization, 
transcriptional processing and functional charac- 
terization through expression would be greatly 
facilitated if full-length cDNA clones, cor- 
responding to the various differentially spliced 
transcripts from the 2-5A synthetase gene, became 
available. Here we have selected a 2-5A synthetase 
cDNA clone by screening our human cDNA 
library prepared from IFN-(r treated cells with an 
oligodeoxyribonucleotide probe derived from the 
522 nucleotide sequence described by Merlin et al. 
[14]. From the 1378 nucleotide sequence of this 
new cDNA clone, we have derived the complete 
amino acid sequence of the 42 kDa 2-5A syn- 
thetase encoded by the 1.6 kb RNA. Furthermore, 
the coding region has been subcloned into an SP6 
vector which allows &l-free transcription. The 
recombinant plasmid was used to direct the syn- 
thesis of microgram amounts of capped RNA in an 
‘in vitro’ transcription system. When injected into 
Xenopus oocytes, this RNA directs the synthesis of 
a fully active enzyme, which is found in both the 
nucleus and cytoplasm, and is presumably active in 
its monomeric form. 
2. MATERIALS AND METWODS 
2.1. ~~epara fio~ and sizer&g of a &VA Hxary 
from a(-IFN treated cellos 
Total cellular RNA was prepared by extraction 
in 8 M guanidine hydrochloride [ 151 of human am- 
niotic U ceils (UAC) that had been grown in roller 
bottles and treated for 6 h at 37°C with 200 U/ml 
of partially purified tu-IFN. After oligo(dT) 
cellulose chromatography, this RNA was frac- 
tionated on a 5-20% sucrose/50% formamide 
gradient as described [16] and the 16-25 S region 
of the gradient was used for cDNA synthesis. We 
used the method described in f17] with the foliow- 
ing modifications: in the first strand cDNA syn- 
thesis, Na s pyrophosphate was omitted, and 
‘Super’ reverse transcriptase from avian 
myeloblastosis virus was used (from Anglian 
Biotechnology-Stehelin); for the second strand 
synthesis, Tq DNA ligase (100 U/ml) was used in- 
114 
stead of E. coli DNA ligase and the incubation was 
carried out overnight at 14’C; cDNA was tailed 
with dCTP and annealed to G-tailed PsiI-cut 
pBR322 ~pur~hased from BRL). Transformation 
was done on CaClz treated MC1061 E. co& and the 
cells were plated and handled at high density exact- 
ly as described [IS]. About 10-30000 clones were 
replicated from each 82 mm nitrocellulose filter. 
Duplicate replicas were screened by hybridization 
with an o~godeoxy~bonucleotide (5 ’ -CTAA- 
GGACCTTGTCTCACAGAGTTC-3 ’ ) that was 
synthesized following the procedure of Sproat and 
Bannwarth [19], following the sequence published 
for the human 2-SA synthetase cDNA [14]. This 
oligonucieotide was labeled by kination with 
fy-32P]ATP to 2-5 x 10s cpm/pg ]20]. Hybridiza- 
tion was performed as described in [ 181 at 52°C ex- 
cept that the medium contained heparin (50 U/ml) 
and 6 x SSC instead of 6 x SET (SET is 0.15 M 
NaCi, 30 mM Tris, pfl 8, 1 mM EDTA). After 
hybridization, the filters were washed 4 times in 6 
x SSC, 0.5% SDS at 20°C and for 5 min at 52°C. 
Two clones (p2-5A-1 and p2-5A-2) were selected. 
After two rounds of purification and hybridization 
at intermediate and low density, the clones were 
amplified and the CsCl purified plasmid DNA 
characterized by restriction analysis. 
2.2. DNA sequence analysis 
First, p2-5A-1 was digested by HndIII, Hind111 
and PvarII, PstI and PvuII, and PstI and SacI. The 
corresponding fragments deriving from the cDNA 
insert were resolved by agarose gel eleetrophoresis, 
electroeluted and subcloned into M13mplO and 
mpll and used to transform E. coli JMlOl. 
SEcOnd, a 0.7 kb PHI fragment from p2-5A-1 was 
digested by Ah1 or Sau3AI and the resulting 
fragments were cloned in Ml 3mplO and mpl 1. 
Single-stranded DNA from the resulting plaques 
was hybridized to a 17 bp Ml3 sequencing primer 
and the sequence of the DNA was analyzed by the 
dideoxy-chain termination method using “S- 
labeled dATP as the labeled nucleotide [21,22]. 
The 5’-Pstf-PvuII fragment, containing the GC 
tail, was labeled with ~~-~~P]dideoxyadenosin~ 
5 ’ -triphosphate using terminal transferase (BRL 
kit), The fragment was then digested with SphI, 
resolved on a polyacrylamide gel and the eluted 
PsA-SphI fragment was sequenced according to 
Maxam and Gilbert [23]. 
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2.3. ~~~~l~~ing of p2-5A-1 into pSP64 2.6. ~icroinjection of RNA into Xenopus oocytes 
As indicated on the restriction map of p2-SA-1 
(fig.l), the entire amino acid coding region could 
not be excised from the pBR322 vector by a com- 
bination of unique proximal and distal restriction 
endonuclease sites. Therefore subcloning of the 
p2-5A-1 coding region into pSP64 was done in 
several steps. First, a 1.5 kb fragment of a partial 
PstI digest was subcloned into pSP64; from the 
resulting construct, a 1.1 kb SphI-EcoRI fragment 
was excised, corresponding to almost the entire 
coding region. Then a 0.65 kb PstI fragment of the 
p2-5A-1 clone was purified and digested by Ai& 
and ZiphI. The 150 bp Al&SpkI fragment was 
purified and ligated with the 1 .l kb SphI-&oRI 
fragment into a SmaI-EcoRI digested pSP64 vec- 
tor, downstream of the SP6 promoter. 
2.4. Cell-free transcription 
The pSP64 2-5A DNA construct was used for 
the synthesis of non-polyadenylated 2-5A syn- 
thetase mRNA after linearization with ,?ZcoRI 
which cleaves at a unique site, 150 nucleotides 
beyond the termination UGA (fig.1). The condi- 
tions for RNA transcription were as described 
in [24] except that the concentration of GTP 
was lowered to 200/~M and that 1 mM 
m’G(5 ‘)ppp(fi ‘)G (PL-Biochemicals) was present 
during transcription. Human placental ribo- 
nuclease inhibitor (Amersham) and SP6 RNA 
polymerase (Boehringer Mannheim) were used for 
transcription. Such a reaction usually yields 1 fig 
homogenous - 16 S RNA on agarose gel per yg 
linearized plasmid DNA transcribed. The RNA 
was isolated from the transcription reaction after 
DNase treatment, phenol extraction and ethanol 
precipitation under the conditions described [24]. 
Groups of 30-60 oocytes were injected with 
50 nl/oocyte of synthetic 2-SA synthetase mRNA 
at a concentration of 0.05-0.5 mg/ml. They were 
incubated for 22-24 h (or other periods of time as 
specified) at 18°C in 1 ml Barth’s medium. Total 
homogenates were prepared by disrupting 30 
oocytes in 150 ~1 buffer B [9] containing 20 mM 
Hepes, 120 mM KCl, 5 mM MgC12, 1 mM DTT, 
0.2% Triton X-100, 10% glycerol, pH 8.0, in a 
teflon glass homogenizer. After centrifugation for 
2 min at 9000 x g the supernatant (with the excep- 
tion for the superficial fat layer) was collected and 
frozen in liquid nitrogen until used. The nuclei 
were isolated by incision of the oocytes at the 
animal pole with a 26G needle, while applying a 
slight pressure on the oocyte, with forceps. The 
nuclei were suspended in a minimal volume of buf- 
fer B (l~~l/lO oocytes) and frozen at -70°C. 
The remaining enucleated oocytes were homo- 
genized as described above for the total oocytes. 
2.7. 2-SA synthetase assay 
Binding of the enzyme to poly(I)* poly(C~- 
agarose beads (P.L.), washing and incubation for 
16 h at 30°C with [a-32P]ATP were exactly as 
described [9,1 I]. 10 /rl of each incubation was then 
made in 30 mM Tris, pH 9, and incubated with 
I U calf intestine alkaline phosphatase for 2 h at 
37’C and spotted onto polyethylene imine cel- 
lulose TLC plates (Macherey Nagel) 1261. Chroma- 
tography in 1 M acetic acid, followed by auto- 
radiography and counting of the radioactive spots 
was as described [26]. 
2.8. Velocity gradient analysis 
2.5. Cell-free translation 
The capped RNA was subjected to cell-free 
translation in a reticulocyte lysate mixture at a 
final concentration of lOO/lg/ml during 90 min at 
33°C in the presence of [?S]methionine and 
[35S]cysteine. The conditions for translation in the 
rabbit reticulocyte lysate and for analysis of the 
translated products by polyacrylamide gel elec- 
trophoresis were as described in 1251 and 
fluorography of the gel was done with Amplify 
(Amersham). 
Extracts of oocytes prepared as described above 
were centrifuged in 15-30% glycerol gradients in 
buffer B containing lo-’ M phenylmethane- 
sulfonyl fluoride. Samples of 100 ~1 were layered 
onto the gradient and centrifuged for 16 h at 
~~ rpm and 4°C in an SW60 Beckman rotor. 
Fractions of 200 ~1 were collected and analyzed for 
enzyme content as described above. Markers 
(50000 cpm) of ‘251-goat-IgG were analyzed in the 
same gradient. The - 160 kDa protein dissociates 
under partially reducing conditions into light chain 
(25 kDa), heavy chains (52 kDa average value) and 
a heavy-light chain complex (77 kDa average 
value). 
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-94 
A ACT GAA ACC 
-36 
TOG GAG GCA GTT 
25 
GCC AAA TCT CTG 
Ala Lys Ser Leu 
85 
CAA ATC AAC CAT 
Gln Ile Am His 
145 
AGC TCC TAC CCT 
Ser Ser Tyr Pro 
205 
ACC CTC AGA GGC 
Thr Leu Arg Gly 
265 
CAG OAT GAG TTA 
Gln Asp Gln Leu 
325 
AAC AGC AGT CCA AGC 'TCA GTC AGC 
CTG TTG CCA CTC TCT CTC CTG TCA 
GAC AAG TTC ATT GAA GAC TAT CTC TTG CCA GAC ACG 
Asp Lys Phe Ile Glu Asp Tyr Leu Leu Pro Asp Thr 
GCC ATT GAC ATC ATC TOT GGG TTC CTG AAG GAA AGG 
Ala Ile Asp Ile Ile Cys Gly Phe Leu Lys Glu Arg 
GTG TGT GTG TCC AAG GTG GTA AAG GOT GGC TCC TCA 
Val Cys Val Ser Lys Val Val Lys Gly Gly Ser Ser 
CGA TCT GAC GCT GAC CTG GTT GTC TTC CTC AGT CCT 
Arg Ser Asp Ala Asp Leu Val Val Phe Leu Ser Pro 
AAT CGC COG GGA GAG TTC ATC CAG GAA ATT AGG AGA 
Asn Arg Arg Gly Glu Phe 11s Gln Glu Ile Arg Arg 
AGA AGA OAT AAA 
1 
ATG ATG OAT CTC 
Met Met Asp Leu 
TGT CAA AGA GAG AGA CiCA TTT TCC GTG AAG TTT GAG GTC CAG GCT CCA 
Cys Gin Arg Glu Arg Ala Phe Ser Val Lys Phe Glu Val Gln Ala Pro 
385 
CCC COT GCG CTC AGC TTC GTA CTG AGT TCG CTC CAG CTC GGG GAG GGG 
Pro Arg Ala Leu Ser Phe Val Leu Ser Ser Leu Gin Leu Gly Glu Gly 
445 
GTG CTG CCT GCC TTT OAT G&C CTG GGT GAG TTG ACT GGC AGC TAT AAA 
Val Lcpu Pro Ala Phe Asp Ala Leu Gly Gln Leu Thr Gly Ser Tyr Lys 
505 
ATC TAT GTC AAG CTC ATC GAG GAG TGC ACC GAC CTG CAG AAA GAG GGC 
Ile Tyr Val Lys Leu Ile Glu Glu Cys Thr Asp Leu Gln Lys Glu Gly 
565 
TGC TTC ACA GAA CTA CAG AGA GAC TTC CTG AAG CAG CGC CCC ACC AAG 
Cys Phe Thr Glu Leu Gln Arg Asp Phe Leu Lys Gin Arg Pro Thr Lys 
625 
ATC CGC CTA GTC AAG CAC TGG TAC CAA AAT TOT AAG RAG AAG CTT GGG 
Ile Arg Leu Val Lys His Trp Tyr Gln Asn Cys Lys Lys Lys Leu Gly 
685 
CAG TAT GCC CTG GAG CTC CTG ACG GTC TAT GCT TGG GAG CGA 000 AGC 
Gln Tyr Ala Leu Glu Leu Leu Thr Val Tyr Ala Trp Glu Arg Gly Ser 
745 
TTC AAC ACA GCC CAG GGA TTT COO ACG GTC TTG GAA TTA GTC ATA AAC 
Phe Asn Thr Ala Gln Gly Phe Arg Thr Val Leu Glu Leu Val Ile Asn 
805 
TGC ATC TAC TGG ACA AAG TAT TAT GAC TTT AAA AAC CCC ATT ATT GAA 
Cys Ile Tyr Trp Thr Lys Tyr Tyr Asp Phe Lys Asn Pro Ile Ile Glu 
865 
AGO CAG CTC ACG AAA CCC ACG CCT GTG ATC CTG GAC CCG GCG GAC CCT 
Arq Gin Leu Thr Lys Pro Thr Pro Val Ile Leu Asp Pro Ala Asp Pro 
925 
GGT GOT GGA GAC CCA AAG CGT TGG AGG CAG CTG GCA CAA GAG GCT GAG 
Gly Gly Gly Asp Pro Lys Arg Trp Arg Gln Leu Ala Gln Glu Ala Glu 
985 
TAC CCA TGC TTT AAG AAT TOG GAT GGG TCC CCA GTG AGC TCC TOG ATT 
Tyr Pro Cys Phe Lys Asn Trp Asp Gly Ser Pro Val Ser Ser Trp Ile 
1045 (364) 
CCT CCT GCT TCC TCC CT0 CCA TTC ATC CCT GCC CCT CTC CAT GAA GC!T 
Pro Pro Ala Ser Ser Leu Pro Phe Ile Pro Ala Pro Leu His Glu Ala 
1105 
CTG GAG ACC ATT CTT TCC AAA GAA CTT ACC TCT TGC CAA AGG CCA TTT 
1165 
TGA CAD GCT GTG CTC CAT ATT TTA CAG TCA TTT TOG TCA CAA TCG AGG 
1225 
TTC ACA TCC CTT OTC CAG AAT TCA TTC CCC TAA GAG TAR TAR TAA ATA 
AGC AAA CAG GTC 
(8) 
AGA AAT ACC CCA 
Arg Asn Thr Pro 
(20) 
TGT TTC CGC ATG 
Cys Phe Arg Met 
(48) 
TGC TTC CGA GOT 
Cys Phe Arg Gly 
(68) 
GGC! AAG GGC ACC 
Gly Lys Gly Thr 
(88) 
CTC ACC ACT TTT 
Leu Thr Thr Phe 
($08) 
CAG CT0 OAR GCC 
Gln Leu Glu Ala 
(128) 
CGC TOG GGC AAC 
Arg Trp Gly Asn 
(148) 
GTG GAG TTC OAT 
Val Glu Phe Asp 
(168) 
CCT AAC CCC CAA 
Pro Asn Pro Gln 
(188) 
GAG TTC TCC ACC 
Glu Phe Ser Thr 
(208) 
CTC RAG AGC CTC 
Leu Lys Ser Leu 
(228) 
AAG CTG CCA CCT 
Lys Leu Pro Pro 
(248) 
ATG AAA ACA CAT 
Met Lys Thr His 
(2683 
TAC CAG CAA CTC 
Tyr Gln Gln Leu 
(288) 
AAG TAC CTG AGA 
Lys Tyr Leu Arg 
(308) 
ACA GGA AAC TTG 
Thr Gly Am Leu 
(3283 
GCC TGG CT0 AAT 
Ala Trp Leu Asn 
(348) 
CTG CTG GTG AGA 
Leu Leu Val Arg 
TGA GAC ATA TAG 
ATA TTC ATA TAG 
GTT TCT GGA ATT 
ATC TCT AAC ACC 
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Fig. 1. Restriction map of the 2-5A synthetase cDNA clone (p2-5A-1). The sites represented are those determined by 
restriction. Those deduced from the sequence are not shown, The C box corresponds tothe tail added for cloning. Box 
A corresponds tothe poly(A) segment. The black segment ear the 3’-Hind111 site shows the location of the synthetic 
oligodeoxyribonucleotides us d for screening of the cDNA library. The fragment cloned in SP64 (SP6) starts from the 
Ah1 site at the 5’-end and extends to the EcoRI site at the 3’-end as indicated by the arrows. The sequenced fragments 
and sequence direction are indicated by arrows. Only one fragment was sequenced by the method of Maxam and 
Gilbert: it is labeled M&G. A = AM, Sp = SphI, Pv = PvttII, Ps = PstI, K = KpnI, H = WndIII, S = SacI, E = EcoRI. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of the p2-SA-I cDNA clone 
A cDNA library was prepared from 16-25 S 
poiy(A)+ mRNA obtained from human amniotic 
U cells that had been treated for 6 h at 37°C with 
200 U/ml human IFN+. After screening the 
library with a 25mer oligodeoxyribonucleotide 
probe derived from the published 522 bp sequence 
of a human 2-5A synthetase cDNA [14], we ob- 
tained 2 positive clones (p2-5A-1 and p2-5A-2) 
among the 18000 clones screened. Restriction 
analysis showed that all the restriction sites of the 
3 ‘-end of the cDNA clone described before [ 141 
were present, that both clones were identical except 
that p2-5A-1 possesses a 300 bp longer insert and 
that the anticipated location of the oligodeox- 
yribonucleotide probe used for screening was con- 
firmed by hybridizing Southern blots of p2-5A-1 
with this oligonucleotide. The restriction map sug- 
gests that p2-5A-1 is entirely homologous to the 
cDNA described before [14] but extends about 
800 bp towards the presumed 5 ‘-end of the 
mRNA. The very large size of the cloned cDNA in- 
sert suggested that it could correspond to a full-size 
cDNA copy of the 2-5A synthetase mRNA. A 
Northern blot analysis using the 5 ’ -PstI-MI frag- 
ment demonstrated the strong induction by 
200 U/ml of cu-IFN of 1.6 and 1.8 kb mRNAs and 
also several larger RNAs in agreement with 
previous reports [10,14] (not shown). 
3.2. Nucleotide sequence of the 2-5A synthetase 
cDNA 
Ml3 subclones of overlapping fragments were 
isolated and sequenced by the dideoxy-chain ter- 
mination method [21,22]. Nucleotides - 94 to - 26 
were also determined using the chemical degrada- 
tion method [23]. The segments equenced are in- 
dicated in fig. 1. The cDNA insert of p2-5A-1 con- 
tains 1402 bp derived from the 2-5A synthetase 
mRNA including a poly(A) tail of 24 nucleotides 
(fig.2). It consists of a segment of 94 nucleotides of 
the 5 ‘-non-coding region, a coding segment of 
1092 nucleotides, a TGA termination triplet and a 
3 ‘-non-coding segment of 192 nucleotides, fol- 
lowed by the poly(A) tail. The coding part of this 
molecule corresponds to a polypeptide of 364 
amino acids having a calculated molecular mass of 
41905 Da. It should benoted here that the 5’-non- 
Fig.2. Nucleotide sequence of human 2-SA synthetase cDNA. The nucleotide sequence of the human 2-SA synthetase 
cDNA insert p2-SA-1 is presented as well as the amino acid sequence translated from the only long open reading frame. 
The numbers on the left refer to the nucleotide number starting with the adenosine of the initiating ATG. The numbers 
in brackets on the right refer to the amino acid number starting with the initiating methionine. 
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coding region of the cDNA presents an open 
reading frame. It is however thought that the pro- 
tein really starts at the indicated ATG since the 
molecular mass of the protein encoded agrees with 
the published value [14]. 
3.3. Ceil-free translation of the p2-5A-I cDNA 
insert 
To verify the molecular mass, enzymatic activity 
and cellular localization of the protein encoded by 
the cDNA described above, we have subcloned a 
portion of this cDNA extending from the 5 ‘-AluI 
to the EcoRI site (see fig.1) into an SP64 vector 
and obtained a construction named SP64-2-5A 
(see section 2). By transcribing this plasmid DNA 
with the SP6 RNA polymerase we obtained a pure 
capped non-polyadenylated synthetic 2-5A syn- 
thetase mRNA. This RNA was efficiently 
translated into a labeled single protein having an 
apparent molecular mass of 39 kDa in a SDS- 
polyacrylamide gel (fig.3) indicating that most 
likely the first or second AUG indicated in fig.2 is 
functional. The molecular mass determined ex- 
perimentally in fig.3 is in good agreement with the 
calculated molecular mass (42 kDa) based on the 
sequence described (fig.2). Furthermore we asked 
whether the protein translated from this synthetic 
2-5A synthetase mRNA was functional. This 
could not be tested easily by translation in rabbit 
reticulocyte lysates since such extracts contain 
123 
Fig.3. Cell-free translation of the mRNA corresponding 
to the 2-SA synthetase insert. Rabbit reticulocyte lysate 
was used for translation of the RNA transcribed invitro 
on the SP64-2-SA DNA linearized with EcoRI. Lanes: 
1, no RNA added; 2, RNA was added at final 
concentration f 100 &ml; 3, molecular mass markers. 
abundant amounts of endogenous rabbit 2-5A 
synthetase [13]. For this reason the SP64-2-5A- 
derived mRNA was injected into Xenopus oocytes 
that were incubated for various periods of time 
before homogenization and measurement of their 
content in 2-5A synthetase. A high level of 2-5A 
synthetase was found in homogenates from 
oocytes that had been injected with 2-25 ng RNA 
per oocyte. In the oocyte cytoplasm the 2-5A syn- 
thetase activity increased between 24 and 48 h in- 
dicating that either the injected synthetic mRNA or 
the enzyme, or both are stable in the oocyte for this 
period of time. Interestingly, when the oocyte 
nuclei were dissected and assayed separately from 
the cytoplasmic extracts for 2-5A synthetase ac- 
tivity lo-30% of the total enzymatic activity was 
obtained in the nuclear fraction. Since the ‘accessi- 
ble’ nuclear volume is about 12% of the total 
oocyte volume [27], this indicates that the 42 kDa 
2-5A synthetase always migrates to some extent 
into the nuclei and that in some experiments it 
I. INA 111, A4 b mm1 nlu.*b 
CNCNCNCN 
W2A 
-(A&A 
ATP 
Fig.4. Chromatography on polyethyleneimine-cellulose 
thin layer sheets of 2-5A molecules ynthesized from 
ATP in the presence of 2-5A synthetase and dsRNA. 
This enzyme was obtained after purification on polyI-C 
Sepharose of extracts from frog oocytes microinjected 
with synthetic 2-5A synthetase mRNA. This RNA was 
transcribed in vitro on the SP64-2-SA plasmid 
linearized with EcoRI. Production of 2-SA was 
measured either in the cytoplasmic (C) or the nuclear (N) 
extract of the oocytes (5 oocytes per lane). As indicated, 
the oocytes were incubated for 24 or 48 h after injection. 
ApA corresponds to dimers and (Ap)fi to trimers of 
2-5A. Tetramers are not completely resolved from 
ATP. 
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reaches a concentration 2-fold higher than that 
found in the cytoplasm. On the other hand the 
42 kDa 2-5A synthetase could possibly function 
as an oligomer containing either several subunits 
or would associate with other polypeptide(s) to 
constitute an enzymatically active structure, this 
pattern of association being different in the 
nuclear and cytoplasmic compartment. In the 
following experiment, we show that such a quater- 
nary structure certainly does not occur in Xenopus 
oocytes and is not required for binding to double- 
stranded RNA or for expressing the 2-5A syn- 
77 K 52K 25K 
I I I 
Fig.5. Size determination of the 2-SA synthetase 
enzymatic activity translated in frog oocytes after 
injection of the synthetic 2-Sk synthetase mRNA. 
lOO/rl of cytoplasmic extract from 40 frog oocytes was 
fractionated by centrifugation in a glycerol gradient. 
The 2-SA synthetase activity was assayed on each 
fraction by measurement on thin layer chromatograms 
of the [32P]2-5A synthesized as described. Markers were 
partially reduced, 1251-labeled goat-IgG (see section 2). 
thetase activity of the oocyte-translated 42 kDa 
2-5A synthetase. When homogenates from 
oocytes that had been injected with 25 ng/oocyte 
of synthetic 2-5A synthetase mRNA and in- 
cubated for 24 h at 18°C were analyzed by 
sedimentation through glycerol gradients, all the 
2-5A synthetase activity was localized in a region 
of the gradient corresponding to an approximate 
size of 50 kDa. If these results can be transposed 
to human cells [27], this would indicate that the 
42 kDa 2-5A synthetase could correspond to part 
or the totality of the IFN-induced nuclear 2-5A 
synthetase and to the small 2-5A synthetase 
described in the cytoplasm of human cells [lo]. So 
far it is still not clear which RNA, related or not 
to the existing clones, codes for the large human 
cytoplasmic enzyme [ 12,131. Thus it remains possi- 
ble that another gene exists which contains the in- 
formation for this larger 2-5A synthetase. 
ADDENDUM 
When this manuscript was ready for publica- 
tion, the sequence of the same 2-5A synthetase 
cDNA was published by Benech et al. [28]. The 
5’-untranslated region of this cDNA is 58 
nucleotides shorter than our p2-5A-1 clone. One 
also notes in these sequences 2 base differences: at 
position 91, a guanine instead of an adenine. This 
means at the level of the protein that aspartic acid 
is in the place of asparagine. Similarly at position 
343 a cytidine is present in the sequence of Benech 
et al. instead of thymidine, resulting in a triplet 
coding for leucine rather than phenylalanine. This 
may be the reflection of polymorphism which may 
exist in this human 2-5A synthetase gene. It may 
also be the result of cloning artefacts. It should be 
stressed here that the protein encoded by our 
cloned cDNA appears to be fully active (it pro- 
duces 2-5A tetramers as shown in fig.4). It would 
be interesting to compare its specific activity with 
that of the enzyme described by Benech et al. in 
comparable expression conditions. 
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